Skip to main content
. 2020 Aug 14;9(8):2647. doi: 10.3390/jcm9082647

Table 2.

Quantitative descriptive data for athletes with CLPP, healthy athletes and total sample.

Quantitative
Data
Total Sample
(N = 30)
CLPP Athletes
(n = 15)
Healthy Athletes
(n = 15)
p-Value
Age (years) 26.50 ± 7 28.00 ± 10 24.00 ± 5 NS
(20–35) (20–35) (20–35)
Weight (kg) 76.98 ± 9.40 75.00 ± 10.90 78.95 ± 7.48 NS *
(53–96) (53–92) (65–96)
Height (m) 1.81 ± 0.08 1.81 ± 0.10 1.81 ± 0.07 NS *
(1.63–1.98) (1.63–1.98) (1.68–1.95)
BMI (kg/m2) 24.03 ± 2.14 23.85 ± 4.50 24.07 ± 1.83 NS
(17.31–27.15) (17.31–25.43) (22.78–27.15)
IPAQ (METS/min/week) 3889.50 ± 3252.00 4266.00 ± 2856.00 3198.00 ± 2883.00 NS
(1935–19272) (1935–19272) (2376–9216)
RMDQ 3.00 ± 3 3.00 ± 3 - -
(0–11) (0–11) -
Nijmegen 6.50 ± 8 6.00 ± 12 7.00 ± 6 NS
(1–23) (2–23) (1–15)

Abbreviations: BMI, body mass index; CLPP, chronic lumbo-pelvic pain; IPAQ, International Physical Activity Questionnaire; METs, metabolic equivalent index per week; NS, no significant; RDMQ, Roland–Morris Disability Questionnaire. * Mean ± standard deviation and range (min–max) as well as Student´s t-test for independent samples were used according to parametric distributions (Shapiro–Wilk test showing a p-value ≥ 0.05). Median ± interquartile range and range (min–max) as well as Mann–Whitney U test were applied according to non-parametric distributions (Shapiro–Wilk test showing a p-value < 0.05). For all analyses, p < 0.05 (for a confidence interval of 95%) was considered as statistically significant.